Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High on-treatment platelet reactivity in ICU patients on aspirin
2012-002226-76Phase 3Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Primary: Change in arachidonic acid-induced platelet aggregation after aspirin intervention. Started Oct 2012; status: terminated.
02
Drugs
aspirin
Beyond the preview
Go deeper on 2012-002226-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002226-76.